Welcome to the ValueWiki PALADIN LABS INC. (PLB:CA) article! Register for free or click the "edit" link to contribute!

PALADIN LABS INC. (PLB:CA)

PALADIN LABS INC. is a pharmaceutical company focused on acquiring or in-licensing pharmaceutical products.Summary from Toronto Stock Exchange

Today

Max

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

12/23/08 8:12 am	Paladin Labs Inc. Acquired ViRexx Medical Corp. (CCNMatthews)
12/22/08 7:12 am	Prostrakan and Paladin Complete Agreement for Abstral(R) and Sancuso(R) (CCNMatthews)
12/15/08 8:12 am	Paladin Labs Announces Automatic Share Purchase Plan (CCNMatthews)
11/28/08 2:11 pm	Investment Industry Regulatory Organization of Canada - Trade Resumption - Paladin Labs Inc. - PLB (CNW Group)
11/28/08 2:11 pm	Paladin Labs and GlaxoSmithKline Inc. Sign Agreement on Dexedrine(R) and Mark Start of a New Strategic Relationship (CCNMatthews)
11/28/08 2:11 pm	Investment Industry Regulatory Organization of Canada - Trading Halt - Paladin Labs Inc. - PLB (CNW Group)
11/06/08 7:11 am	Paladin Reports Record Third Quarter 2008 Financial Results (CCNMatthews)
10/30/08 7:10 am	Notice of Paladin Labs' Third Quarter Results Conference Call (CCNMatthews)
09/25/08 3:09 pm	Paladin to Present at BioContact Conference in Quebec City (CCNMatthews)
09/19/08 7:09 am	Paladin to Present at the UBS Global Life Science Conference in New York (CCNMatthews)